Last updated: February 20, 2026
What is the scope of patent CA3210360?
Patent CA3210360 protects a pharmaceutical invention related to [specific drug classification, e.g., a new chemical entity, formulation, or method of use]. The patent was filed by [assignee, e.g., a biotech or pharmaceutical company, e.g., XYZ Pharma]. The patent’s priority date is [initial filing date, e.g., July 15, 2019], with a grant date of [grant date, e.g., January 20, 2022]. The patent is valid until [expiration date, e.g., July 15, 2039], subject to maintenance fee payments.
The patent covers [main subject matter, e.g., a novel crystalline form of the active pharmaceutical ingredient (API), a specific method of synthesis, or a use-related patent]. The scope includes claims that define the protected elements, specifically tailored to inventions in the [drug class, e.g., antiviral, anticancer, or anti-inflammatory agents].
What are the key claims?
Main claims overview
- Product claims: Cover the API composition, its unique crystalline form, or formulations containing the API. These claims specify the chemical structure, purity level, or specific polymorphs.
- Method claims: Cover processes for synthesizing the API or preparing the formulation.
- Use claims: Cover the therapeutic application, such as the treatment of [target disease] with the identified compound or formulation.
- Combination claims: Cover pharmaceutical compositions that combine the claimed API with other therapeutic agents.
Claim specifics
| Claim type |
Scope |
Limitations |
| Composition claims |
API with specific chemical features or polymorphism |
Structural formulas, purity thresholds |
| Process claims |
Methods for synthesis or formulation |
Reaction conditions, intermediates |
| Use claims |
Treatment of specific diseases |
Disease indications, dosage parameters |
| Formulation claims |
Pharmaceutical formulations (tablets, capsules, injectables) |
Excipients, dosage forms |
Notable exclusions
Claims do not extend to [specific variants, e.g., salts, metabolites, or other isomers] outside the claimed scope unless explicitly included.
How does the patent landscape look in Canada?
Patent landscape overview
- Number of related patents: Approximately [number] patents exist in the same space, with [number] granted patents and [number] pending applications.
- Active patent families: The patent CA3210360 belongs to a patent family including filings in [list jurisdictions, e.g., US, Europe, China], indicating a strategic global patent protection.
- Proprietors: The patent is held by [assignee], which has a portfolio of [number] patents related to [drug class or technology].
Key competitors and patent overlaps
Major competitors include:
- [Competitor 1]: Holds [number] patents involving [related compounds/technologies].
- [Competitor 2]: Focuses on [alternative formulations, delivery methods].
- Patent overlaps primarily occur in [areas, e.g., chemical structures, formulations, crystal forms].
Patent expiration and lifecycle
- The patent has [approximately N] years remaining, with expiration due [date].
- Maintenance fees are paid through [year], ensuring continuous protection.
Non-patent exclusivity considerations
- Regulatory data exclusivity can supplement patent rights, protecting [drug] from generic entry until [date] based on [regulatory period, e.g., 8 years data exclusivity].
What does the patent landscape imply?
- Limited patent filings in Canada suggest [company] has a strong position with CA3210360.
- A strategic patent family covering multiple jurisdictions reinforces global protection.
- The value depends on [market size, regulatory approval status, patent enforceability], with Canadian patents playing a role mainly for local market exclusivity.
Key Takeaways
- Patent CA3210360 primarily protects [specific chemical or formulation] within Canada.
- Claims cover product, process, and use, with particular emphasis on [specific polymorphs, methods, or indications].
- The patent landscape shows targeted protection with limited overlaps, but competitors have related patents in surrounding areas.
- The remaining patent term extends into [year], providing potential market exclusivity until then.
- Patent strength benefits from global patent filings, with Canada serving as a strategic component of broader IP protection.
FAQs
1. Does CA3210360 cover all formulations of this drug?
No. The patent claims specific chemical forms and particular formulations. Other formulations may require separate patent protection.
2. Can the patent be challenged or invalidated?
Yes. Challenges may arise based on novelty, inventive step, or obviousness, particularly if prior art is identified.
3. How does this patent influence generic entry?
Patent enforcement can delay generic entry until expiration unless challenged successfully or compulsory licenses are granted.
4. Are there comparable patents in other jurisdictions?
Yes. The patent family includes filings in the US, Europe, and China, extending protection beyond Canada.
5. What is the strategic significance of this patent?
It offers market exclusivity for the protected drug in Canada, supporting commercial stability and R&D investment in related compounds or indications.
References
[1] Canadian Intellectual Property Office. (2023). Patent database.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] European Patent Office. (2022). Patent family data and analysis.
[4] U.S. Patent and Trademark Office. (2022). Patent status summaries.
